Dec. 7: CO-LABS ROI on Research Series - Dr. Robert Sievers
Updated: Jan 10, 2022
In 2009 Dr. Robert E. Sievers was recognized for his leadership on research to create dry, inhalable vaccines and pharmaceuticals in the category of Public Health for the inaugural "Governor's Award for High-Impact Research" event hosted by CO-LABS and Colorado Governor Bill Ritter. His team innovated a dry delivery technique for the measles vaccine to eliminate the need for injections, liquid storage, refrigeration and other challenges.
For more than 40 years Dr. Sievers has studied analytical chemistry, pharmaceutical science, aerosols, microparticles and nanoparticles, inhalable vaccines and antibiotics, and supercritical fluids.
In this webinar Dr. Sievers will be joined by a few current researchers and scientists who have built on his work and also provide fascinating recent details of the scope of his research devoted to the development of evidence based knowledge regarding the medical benefits of hemp.
This session is part of the CO-LABS "ROI on Research" Series providing updates and inspirational insights to the longer-term impacts and ways brilliant research from scientists in Colorado has manifested over the years. This Series highlights the previous winners of the Governor's Awards for High-Impact Research beginning in 2009.
About the Governor's Awards:
Since 2009 the Governor’s Awards for High-Impact Research has honored Colorado scientists and engineers from the state’s federally funded research laboratories for outstanding achievements. Each year a special committee appointed by the CO-LABS Board of Directors reviews nominations from Colorado’s labs and selects projects that have had a significant global, national or state impact resulting from a scientific breakthrough, change in public policy or development of a new technology.